Halil Aşçı

693 total citations
75 papers, 509 citations indexed

About

Halil Aşçı is a scholar working on Epidemiology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Halil Aşçı has authored 75 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Pathology and Forensic Medicine and 12 papers in Molecular Biology. Recurrent topics in Halil Aşçı's work include Chemotherapy-induced organ toxicity mitigation (9 papers), Acute Lymphoblastic Leukemia research (7 papers) and Preterm Birth and Chorioamnionitis (6 papers). Halil Aşçı is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (9 papers), Acute Lymphoblastic Leukemia research (7 papers) and Preterm Birth and Chorioamnionitis (6 papers). Halil Aşçı collaborates with scholars based in Türkiye, Kazakhstan and Czechia. Halil Aşçı's co-authors include Özlem Özmen, Mehtap Savran, İlter İlhan, Hamit Yaşar Elli̇dağ, Necat Yılmaz, Mehmet Kaya Özer, Yalçın Erzurumlu, Mustafa Saygın, Şükriye Yeşilot and Duygu Kumbul Doğuç and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Food and Chemical Toxicology.

In The Last Decade

Halil Aşçı

59 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Halil Aşçı Türkiye 12 104 93 63 54 48 75 509
Mehtap Savran Türkiye 12 90 0.9× 74 0.8× 34 0.5× 45 0.8× 38 0.8× 47 412
Kevser Tanbek Türkiye 14 99 1.0× 106 1.1× 61 1.0× 53 1.0× 38 0.8× 39 523
Nermeen N. Welson Egypt 13 138 1.3× 66 0.7× 53 0.8× 59 1.1× 33 0.7× 45 526
Eli̇f Oğuz Türkiye 14 114 1.1× 62 0.7× 66 1.0× 35 0.6× 39 0.8× 50 545
Telma de Jesus Soares Brazil 15 101 1.0× 73 0.8× 46 0.7× 35 0.6× 55 1.1× 35 616
Renad Mammadov Türkiye 14 118 1.1× 100 1.1× 54 0.9× 62 1.1× 32 0.7× 76 501
Bahadır Süleyman Türkiye 14 130 1.3× 126 1.4× 67 1.1× 110 2.0× 62 1.3× 84 669
Nihal Cetin Türkiye 13 90 0.9× 151 1.6× 93 1.5× 73 1.4× 48 1.0× 50 560
Atilla Topçu Türkiye 15 88 0.8× 105 1.1× 41 0.7× 40 0.7× 80 1.7× 47 540
Süleyman Demir Türkiye 15 103 1.0× 144 1.5× 72 1.1× 72 1.3× 39 0.8× 41 781

Countries citing papers authored by Halil Aşçı

Since Specialization
Citations

This map shows the geographic impact of Halil Aşçı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halil Aşçı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halil Aşçı more than expected).

Fields of papers citing papers by Halil Aşçı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halil Aşçı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halil Aşçı. The network helps show where Halil Aşçı may publish in the future.

Co-authorship network of co-authors of Halil Aşçı

This figure shows the co-authorship network connecting the top 25 collaborators of Halil Aşçı. A scholar is included among the top collaborators of Halil Aşçı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Halil Aşçı. Halil Aşçı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Aşçı, Halil, et al.. (2025). Protective effects of tasimelteon on kidney injury in a traumatic brain injury rat model: a histopathological and immunohistochemical study. European Journal of Trauma and Emergency Surgery. 51(1). 241–241.
3.
İlhan, İlter, et al.. (2025). Effect of dapagliflozin on sepsis-induced kidney injury in a rat model: modulation of the NLRP3 pathway. Immunopharmacology and Immunotoxicology. 47(4). 533–540.
4.
5.
Aşçı, Halil, et al.. (2024). Enhancing radioprotection: exploring the impact of L-carnitine supplementation on the oxidative stress in the liver. Molecular Biology Reports. 51(1). 1015–1015. 1 indexed citations
6.
Erzurumlu, Yalçın, et al.. (2024). Nebivolol protects the liver against lipopolysaccharide-induced oxidative stress, inflammation, and endoplasmic reticulum–related apoptosis through Chop and Bip/GRP78 signaling. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(8). 5899–5907. 5 indexed citations
7.
Aşçı, Halil, et al.. (2024). “Investigation of the potential cellular changes induced by magnesium sulfate and salubrinal in a lipopolysaccharide-induced chorioamnionitis model”. European Journal of Pharmacology. 982. 176949–176949. 1 indexed citations
8.
9.
10.
11.
Topsakal, Şenay, et al.. (2024). Dapagliflozin prevents reproductive damage caused by acute systemic inflammation through antioxidant, anti‐inflammatory, and antiapoptotic mechanisms. Basic & Clinical Pharmacology & Toxicology. 135(5). 561–574. 6 indexed citations
12.
13.
Aşçı, Halil, et al.. (2023). The ameliorative effects of cannabidiol on methotrexate‐induced neuroinflammation and neuronal apoptosis via inhibiting endoplasmic reticulum and mitochondrial stress. Journal of Biochemical and Molecular Toxicology. 38(1). e23571–e23571. 10 indexed citations
14.
Aşçı, Halil, et al.. (2023). PROTECTIVE ROLE OF SELENIUM ON THE HEART OF RATS EXPOSED ACRYLAMIDE. SHILAP Revista de lepidopterología. 30(1). 9–17. 1 indexed citations
15.
16.
İlhan, İlter, et al.. (2022). Selenium exerts protective effects on inflammatory cardiovascular damage: molecular aspects via SIRT1/p53 and Cyt-c/Cas-3 pathways. Molecular Biology Reports. 50(2). 1627–1637. 14 indexed citations
17.
Yeşilot, Şükriye, et al.. (2022). The ameliorative effect of Acetylsalicylic acid plus Ascorbic acid against renal injury in Corn Syrup-fed rats. DergiPark (Istanbul University). 7(1). 26–33. 1 indexed citations
18.
İlhan, İlter, et al.. (2022). Irbesartan decreased mitochondrial stress related apoptosis in cisplatin induced acute kidney injury via regulating BCL-2/BAX signaling. Molecular Biology Reports. 49(7). 6125–6133. 9 indexed citations
19.
Yalçın, Serenat Eriş, et al.. (2021). Combined Use of Magnesium Sulfate and Fingolimod for Antenatal Neuroprotection against Inflammation-Mediated Experimental Preterm Brain Injury in a Rat Model. Fetal and Pediatric Pathology. 41(4). 603–615. 1 indexed citations
20.
Kaya, Bulem Üreyen, et al.. (2019). Anti‐inflammatory and antiresorptive functions of melatonin on experimentally induced periapical lesions. International Endodontic Journal. 52(10). 1466–1478. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehtap Savran Breakdown of academic impact, for papers by Kevser Tanbek Breakdown of academic impact, for papers by Nermeen N. Welson Breakdown of academic impact, for papers by Eli̇f Oğuz Breakdown of academic impact, for papers by Telma de Jesus Soares Breakdown of academic impact, for papers by Renad Mammadov Breakdown of academic impact, for papers by Bahadır Süleyman Breakdown of academic impact, for papers by Nihal Cetin Breakdown of academic impact, for papers by Atilla Topçu Breakdown of academic impact, for papers by Süleyman Demir
Rankless by CCL
2026